Skip to main content
KANABO GROUP PLC logo

KANABO GROUP PLC — Investor Relations & Filings

Ticker · KNB ISIN · GB00BYQCS703 LEI · 213800XPJFSNWJIYKN52 IL Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2021-03-09 Regulatory Filings
Country GB United Kingdom
Listing IL KNB

About KANABO GROUP PLC

https://www.kanabogroup.com/

Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1914 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange, referencing the RNS Number and RNS distribution service. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This type of brief, immediate regulatory update that doesn't fit a specific financial report category (like 10-K, ER, or IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2021-03-09 English
Medicinal Cannabis Production Agreement
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated March 9, 2021. It announces a 'Medicinal Cannabis Production Agreement' signed by Kanabo Group Plc. The text explicitly mentions that the information is provided by RNS, the news service of the London Stock Exchange, and is subject to Market Abuse Regulation (MAR) disclosure. This structure—a brief announcement of a material event (a new agreement) disseminated via the London Stock Exchange's regulatory news service—is characteristic of a general regulatory announcement that doesn't fit the specific definitions of 10-K, ER, or IR. Since it is a formal regulatory disclosure that doesn't map to a more specific category like DIRS, DIV, or MANG, the most appropriate fallback is Regulatory Filings (RNS). The document length (5319 chars) is substantial enough that it is the announcement itself, not just a pointer to a report, but RNS is the best fit for this type of LSE filing.
2021-03-09 English
Change of Registered Address
Regulatory Filings Classification · 98% confidence The document is very short (2015 characters) and announces a 'Change of Registered Address' for Kanabo Group Plc, effective March 3, 2021. It is distributed via 'RNS Number : 5386R' and explicitly mentions that RNS is the news service of the London Stock Exchange, approved as a Primary Information Provider. This type of administrative, non-financial, mandatory disclosure that doesn't fit into specific categories like Director's Dealing (DIRS) or Capital Changes (CAP) is best classified as a general Regulatory Filing or announcement. Since it is a standard regulatory announcement distributed through the RNS system, the most appropriate code is RNS, which serves as the general regulatory announcement fallback.
2021-03-08 English
UK Medicinal Cannabis Distribution Agreement
Regulatory Filings Classification · 100% confidence The document is identified by the RNS Number header and the explicit mention of 'RNS Number : 9642P' and 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates a regulatory announcement made via the London Stock Exchange's Regulatory News Service (RNS). The content describes a significant business event: signing a UK Medicinal Cannabis Distribution Agreement. This is a material corporate event announcement. Given the nature of the announcement (a material business development) and the source (RNS), it fits best under the general 'Regulatory Filings' category (RNS), as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action like a dividend (DIV) or share transaction (POS). Although it contains 'inside information' under MAR, the primary classification based on the delivery mechanism and content type is RNS.
2021-02-23 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document text explicitly starts with 'RNS Number : 8743P' and contains language typical of regulatory exchange announcements, such as referencing the 'London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a 'Second Price Monitoring Extension' notification, which is a specific type of market operational announcement. Since this is a general regulatory announcement that doesn't fit into the more specific categories like 10-K, ER, or DIV, the most appropriate classification is the general regulatory filing category, RNS (Regulatory Filings). The document length is short (1934 chars), but the content is the announcement itself, not an announcement *about* another report, so RPA is less suitable than RNS for this specific market notice type.
2021-02-22 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1917 characters) and contains the header 'RNS Number : 8738P'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. The text explicitly mentions RNS as the news service approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. This structure—a brief, time-sensitive announcement disseminated via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category. Therefore, it should be classified as a Regulatory Filing (RNS).
2021-02-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.